http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
아급성기 대량 재해 지역에서의 의료 지원 : '99 대만 지진 의료 지원을 중심으로
송형곤,강보승,송근정,정연권 대한응급의학회 2000 대한응급의학회지 Vol.11 No.3
Background: There was a powerful earthquaken(Richter Scale 7.6) In Tiawan, on Sep.21, 1999. We supported the organized medic긴 services in that area during 5 days. Methods: We made the protocol and analyzed the results prospectively. Results: We took care of a total of 708 patients from sep. 23 to sep. 27. Traumatized patients related to the earthquake were 245(34.6%), and most of them had minor injuries. Two hundred thirty-nine(239, 33.8%) patients visited us for medical disease related to living in a group. There were 29(4.1%) patients who complained of neuropsychiatric problems due to the post-earthquaken stress. Because the condition of the patients was so bad, 18(2.5%) were transferred to receive more medical services. Conclusion: In disaster area, organized medical services have two different roles, especially in the subacute stage. One is responsibility for real emergency medical care, and the other is medical care of non-emergency patients.
김병철,강보승,송형곤,이정훈,송근정,정연권 대한응급의학회 1999 대한응급의학회지 Vol.10 No.4
Background : The purpose of this study was to analyze the endotracheal intubation cases performed in the emergency department. Methods : We investigated retrospectively 326 cases of endotracheal intubation performed in the emergency department of a tertiary care center form April 1, 1998 to March 31, 1999. We focused on operators, medications used, its success rate and immediate complications, and the relationship between its success rate and medications. Results : Of 326 consecutive intubations, 193 patients(59.2%) were done by emergency medicine residents or attending physician. While 320 patients(98.2%) were successfully intubated, 6 patients could not be intubated and 2 patients underwent tracheostomy. Of 50 cases of intubations(15.3%) attempted with paralyzing agents, 48 cases were done with succinylcholine and 46 cases underwent by emergency physicians. Intubations with neuromuscular paralysis resulted in high success rates at the first attempt. Of 55 immediate adverse events were encountered in 47 patients(desaturation=17, bronchial intubation=15, hypotension=8, bradycardia=4, cardiac arrest=2, others=5). Conclusion : At this institution, paralyzing agents were used infrequently, but almost all of them were used by emergency physicians.
( Bo Hyoung Kang ),( Kyung-wook Jo ),( Tae Sun Shim ) 대한결핵 및 호흡기학회 2017 Tuberculosis and Respiratory Diseases Vol.80 No.2
Background: Fluoroquinolones are considered important substitutes for the treatment of tuberculosis. This study investigates the current status of fluoroquinolone for the treatment of tuberculosis. Methods: In 2009, a retrospective analysis was performed at one tertiary referral center for 953 patients diagnosed with tuberculosis. Results: A total of 226 patients (23.6%), who received fluoroquinolone at any time during treatment for tuberculosis, were enrolled in this study. The most common reasons for fluoroquinolone use were adverse events due to other antituberculosis drugs (52.7%), drug resistance (23.5%), and underlying diseases (16.8%). Moxifloxacin (54.0%, 122/226) was the most commonly administered fluoroquinolone, followed by levofloxacin (36.3%, 82/226) and ofloxacin (9.7%, 22/226). The frequency of total adverse events from fluoroquinolone-containing anti-tuberculosis medication was 22.6%, whereas fluoroquinolone-related adverse events were estimated to be 2.2% (5/226). The most common fluoroquinolone-related adverse events were gastrointestinal problems (3.5%, 8/226). There were no significant differences in the treatment success rate between the fluoroquinolone and fluoroquinolone-naive groups (78.3% vs. 78.4%, respectively). Conclusion: At our institution, fluoroquinolones are commonly used for the treatment of both multidrug-resistant tuberculosis and susceptible tuberculosis, especially as a substitute for adverse event-related drugs. Considering the low adverse event rates and the comparable treatment success rates, fluoroquinolones seem to be an invaluable drug for the treatment of tuberculosis.
( Bo Hyoung Kang ),( Soo Jung Um ),( Mee Sook Roh ) 대한내과학회 2014 대한내과학회 추계학술발표논문집 Vol.2014 No.1
Background: Pulmonary tuberculosis (TB) is a major public health problem in Korea, a country with an intermediate burden of TB. Due to its high risk of transmission, early diagnosis and treatment is important for disease control. Polymerase chain reaction (PCR) is a useful adjunctive method for rapid diagnosis of TB, especially in combination with bronchoscopy. The aim of this study was evaluating diagnostic accuracy of real time PCR (RT-PCR) and conventional PCR for patients with sputum-smear negative TB. Methods: A retrospective analysis was performed in one tertiary referral center from January 2013 to January 2014. We enrolled sputum-smear negative patients who had lesions on chest CT that suggested pulmonary TB and underwent both RT-PCR and conventional PCR in bronchial aspirate. Results: During study period, 49 patients underwent both RT-PCR and conventional PCR in bronchial aspirate for diagnosing pulmonary TB. Among those patients, 23 patients diagnosed as pulmonary TB. The sensitivity of each method was 48% for RTPCR and 65% for conventional PCR. The specificity was 100% for RT-PCR and 72% for conventional PCR. The positive predictive value was 100% for RT-PCR and 75% for conventional PCR. The negative predictive value was 68% for RT-PCR and 72% for conventional PCR. Conclusion: In this study, we found that RT-PCR was highly specificc test for detecting pulmonary TB, although the sensitivity was relatively low to conventional PCR. So, PCR is useful adjunctive method for patients with sputum-smear negative.
Kang, Bo Hyoung,Jo, Kyung-Wook,Shim, Tae Sun The Korean Academy of Tuberculosis and Respiratory 2017 Tuberculosis and Respiratory Diseases Vol.80 No.2
Background: Fluoroquinolones are considered important substitutes for the treatment of tuberculosis. This study investigates the current status of fluoroquinolone for the treatment of tuberculosis. Methods: In 2009, a retrospective analysis was performed at one tertiary referral center for 953 patients diagnosed with tuberculosis. Results: A total of 226 patients (23.6%), who received fluoroquinolone at any time during treatment for tuberculosis, were enrolled in this study. The most common reasons for fluoroquinolone use were adverse events due to other anti-tuberculosis drugs (52.7%), drug resistance (23.5%), and underlying diseases (16.8%). Moxifloxacin (54.0%, 122/226) was the most commonly administered fluoroquinolone, followed by levofloxacin (36.3%, 82/226) and ofloxacin (9.7%, 22/226). The frequency of total adverse events from fluoroquinolone-containing anti-tuberculosis medication was 22.6%, whereas fluoroquinolone-related adverse events were estimated to be 2.2% (5/226). The most common fluoroquinolone-related adverse events were gastrointestinal problems (3.5%, 8/226). There were no significant differences in the treatment success rate between the fluoroquinolone and fluoroquinolone-$na{\ddot{i}}ve$ groups (78.3% vs. 78.4%, respectively). Conclusion: At our institution, fluoroquinolones are commonly used for the treatment of both multidrug-resistant tuberculosis and susceptible tuberculosis, especially as a substitute for adverse event-related drugs. Considering the low adverse event rates and the comparable treatment success rates, fluoroquinolones seem to be an invaluable drug for the treatment of tuberculosis.
강보형 ( Bo Hyoung Kang ),이호수 ( Ho Su Lee ),이유미 ( Yu Mi Lee ),박소은 ( So Eun Park ),김우성 ( Woo Sung Kim ),김동순 ( Dong Soon Kim ),송진우 ( Jin Woo Song ) 대한내과학회 2012 대한내과학회지 Vol.82 No.3
Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of lipoproteinaceous material within the alveoli. Several studies have recently found that autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) play a major role in the pathogenesis of idiopathic PAP. Consequently, inhaled or systemic injection of GM-CSF has been suggested as a promising treatment for PAP. A 54-year-old male visited our hospital for progressive dyspnea. Four years earlier, he was diagnosed with PAP based on a surgical lung biopsy in another institution. Whole-lung lavage was performed four times before he visited our hospital. We administered high-dose inhaled GM-CSF therapy for 12 weeks followed by 12 weeks of low-dose therapy. After the GM-CSF treatment, the patient`s symptoms, lung function, and radiological findings were improved significantly. (Korean J Med 2012;82:357-361)
( Bo Kyung Yang ),( Byung Ju Do ),( Eun Jung Kim ),( Ji Un Lee ),( Mi Hee Kim ),( Jin Gu Kang ),( Hyoung Su Kim ),( Kyung Ho Kim ),( Myoung Kuk Jang ),( Jin Heon Lee ),( Hak Yang Kim ),( Woon Geon Shi The Editorial Office of Gut and Liver 2014 Gut and Liver Vol.8 No.1
Background/Aims: As the incidence rate of and mortality from pseudomembranous colitis (PMC) are increasing worldwide, it is important to study the simple predictive risk factors for PMC among patients with hospital-acquired diarrhea (HAD). This study focused on identifying the clinical risk factors that can easily predict PMC. Methods: The presumed HAD patients were prospectively recruited at the Hallym University Kangdong Sacred Heart Hospital. Results: Age of 70 and older (adjusted odds ratio [OR], 1.76, 95% confidence interval [CI], 1.12 to 0.75), use of proton pump inhibitors (adjusted OR, 4.07, 95% CI, 2.512 to 6.57), use of cephalosporins (adjusted OR, 2.99, 95% CI, 1.82 to 4.94), and underlying cancer (adjusted OR, 1.72, 95% CI, 1.04 to 2.82) were independent risk factors for PMC in the multivariate logistic regression analysis. The prevalence of PMC was very low in the patients with HAD who exhibited no risk factors. Conclusions: The risk factors for PMC in patients with HAD included cephalosporin use, proton pump inhibitor use, old age, and cancer. Considering the strongly negative predictive values of these risk factors, endoscopic evaluation can be delayed in patients with HAD without risk of developing PMC. (Gut Liver 2014,8:41-48)